10 Dec 2020
India, the world’s biggest maker, is getting set for a massive global blitz to contain the pandemic, with its pharmaceutical industry and partners freeing up capacity and accelerating investments even without firm purchase orders.
India manufactures more than 60% of all vaccines sold across the globe, and while its $40 billion pharmaceutical sector is not yet involved in the production of the expensive Pfizer and Moderna shots, the nation will play a pivotal role in immunizing much of the world.
Indian companies are set to produce eight, more affordable vaccines, including AstraZeneca’s Covishield, called the “vaccine for the world” by its developers.